Blogs

Could your diet be triggering your migraines? Certain foods, from aged cheese to red wine, might be the culprit behind those debilitating headaches. Learn which common foods to watch for and how to identify your personal triggers.

Unexplained numbness, tingling, or muscle weakness could be signs of a nerve or muscle disorder. Electrodiagnostic medicine helps pinpoint the cause so you can get the answers you need to develop the proper treatment.

Curious about clinical trials but not sure if they’re right for you? They’re critical for advancing medical treatments, but many people don’t realize how they can benefit from participating. Learn more about how they work and why they matter.

Worried about your memory? Get a free cognitive assessment! Learn what to expect during the 15-minute evaluation and discover potential next steps like consulting with a neurologist or participating in clinical trials. Schedule a free cognitive testing NOW

Dementia affects millions, altering memory, thinking, and daily life. Here we explore the basics of dementia, from signs and diagnosis to managing care with empathy. Explore expert tips to support your loved one, and yourself, on this journey.

We are pleased to announce advancements in Alzheimer’s Disease research, stemming from the Phase 3 LUCIDITY trial!

A new study in The Lancet Neurology has brought hope to both researchers and patients, as it presents a novel way to test for Parkinson's disease even before any symptoms show up.

Parkinson's disease afflicts over one million people in the United States causing a decline in motor skills and cognition due to the destruction of dopamine producing neurons in the brain. Current research targets dopamine receptors in the brain.

Neurology Diagnostics is proud to announce our participation and enrollment of patients in the Eli Lilly Alzheimer's disease study recently reported in the New York Times.

October 17, 2023 - Neurology Diagnostics’ Role in Advancing Alzheimer’s Research: LUCIDITY Phase 3 Outcomes - NDX Research Clinic Updates - New Referral Process - Accepting New Patients

Neurology Diagnostics Newsletter Summary [date] Accepting new patients, streamlined referrals, FDA-approved Alzheimer's drug Leqembi, and upcoming clinical trials for Alzheimer's, CTE, and Parkinson's. Join us in advancing neurological care.

We are thrilled to share that the FDA has granted approval for Leqembi, a groundbreaking drug that offers new hope for Alzheimer's patients. Leqembi is an antibody that targets amyloid in the brain, in order to slow the progress of Alzheimer’s.

Neurology Diagnostics (NDx) is proud to have been selected for Lilly's ALZ 2 Trailblazer trial and has been seeing patients in this trial since July 2020. As part of the study, NDx has randomized 39 patients of the trial's >1700 patients

Neurology Diagnostics is proud to announce that their primary neurologist, Dr. Joel Vandersluis, has been selected as a 2023 Health Care Hero.

What is clinical research? How do we do it, why is it important, and how can you get involved?